Schonfeld Strategic Advisors’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
77,264
-25,442
| -25% | -$129K | ﹤0.01% | 1525 |
|
|
2025
Q1 | $310K | Buy |
102,706
+39,071
| +61% | +$118K | ﹤0.01% | 1643 |
|
|
2024
Q4 | $230K | Sell |
63,635
-322,949
| -84% | -$1.17M | ﹤0.01% | 1652 |
|
|
2024
Q3 | $680K | Buy |
386,584
+347,684
| +894% | +$612K | ﹤0.01% | 1171 |
|
|
2024
Q2 | $60.7K | Buy |
38,900
+18,400
| +90% | +$28.7K | ﹤0.01% | 1777 |
|
|
2024
Q1 | $40K | Buy |
+20,500
| New | +$40K | ﹤0.01% | 1717 |
|
|
2023
Q3 | – | Sell |
-11,100
| Closed | -$24K | – | 2171 |
|
|
2023
Q2 | $24K | Buy |
+11,100
| New | +$24K | ﹤0.01% | 1758 |
|